Clinical Trials Using Tetravalent RNA-lipoplex Cancer Vaccine

Clinical trials are research studies that involve people. The clinical trials on this list are studying Tetravalent RNA-lipoplex Cancer Vaccine. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Trial With BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Anti-PD1-refractory / Relapsed, Unresectable Stage III or IV Melanoma

    This is an open-label, randomized, multi-site, Phase II, interventional trial designed to evaluate the efficacy, tolerability, and safety of BNT111 + cemiplimab in anti-PD1-refractory / relapsed patients with unresectable Stage III or IV melanoma. The contributions of BNT111 and cemiplimab will be delineated in single agent calibrator arms. Patients in single agent calibrator arms, who experience disease progression under single agent treatment, may be offered addition of the other compound to the ongoing treatment after re-consent.
    Location: University of Iowa / Holden Comprehensive Cancer Center, Iowa City, Iowa